Answers are grounded in this paper and cite their sources.
The need for safe and effective antifungal agents increases in parallel with the expanding number of immunocompromised patients at risk for invasive fungal infections. The emergence of fungal pathogens resistant to current therapies further compounds the dearth of antifungal agents. Currently
No takes yet. Share an insight, caveat, or question.
Lucca et al. (1999) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: